Application 204017

Type
NDA
Sponsor
AGILE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TWIRLAETHINYL ESTRADIOL; LEVONORGESTRELSYSTEM;TRANSDERMAL0.03MG/24HR;0.12MG/24HRYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
71671-100Twirlalevonorgestrel/ethinyl estradiolAgile Therapeutics, Inc.NDACurrent
71671-100Twirlalevonorgestrel/ethinyl estradiolAgile Therapeutics, Inc.NDACurrent
71671-100Twirlalevonorgestrel/ethinyl estradiolAgile Therapeutics, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84204SUPPL 2025-11-19
70947SUPPL2022-05-03
70890SUPPL2022-05-02
62745ORIG2020-04-30
61905ORIG2020-02-18
61904ORIG2020-02-18